memantine has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of 18 benign prostatic hyperplasia (BPH) specimens, none had stromal NMDAr staining, but 2 had low and 1 had high epithelial NMDAr immunoreactivity." | 1.33 | N-methyl-D-aspartate receptor in human prostate cancer. ( Abdul, M; Hoosein, N, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, M | 1 |
| Hoosein, N | 1 |
1 other study available for memantine and Prostatic Hyperplasia
| Article | Year |
|---|---|
N-methyl-D-aspartate receptor in human prostate cancer.
Topics: Breast; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cysteine; Dizocilpine Ma | 2005 |